Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration

Gomes, Catarina V., Kaster, Manuella P., Tomé, Angelo R., Agostinho, Paula M., Cunha, Rodrigo A.·2011·Biochimica et Biophysica Acta (BBA) - Biomembranes
DOI 10.1016/j.bbamem.2010.12.001

Cites (473)

Items 401–475 of 475

  1. Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease
    Iolanda D’Alimonte, Mariagrazia D’Auro, Rita Citraro, Francesca Biagioni, Shucui Jiang, Eleonora Nargi, Silvana Buccella, Patrizia Di Iorio, Patricia Giuliani, Patrizia Ballerini et al. · 2009 · European Journal of Neuroscience
  2. Adenosine A2A receptors inhibit the N-methyl-d-aspartate component of excitatory synaptic currents in rat striatal neurons
    Zoltán Gerevich, Kerstin Wirkner, Péter Illés · 2002 · European Journal of Pharmacology
  3. Caffeine Impairs Short-term Neurological Outcome after Concussive Head Injury in Rats
    Khalaf Al Moutaery, Saleh Al Deeb, Haseeb Ahmad Khan, Mohammad Tariq · 2003 · Neurosurgery
  4. Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices
    Cláudia Guimas Almeida, Alexandre de Mendonça, Rodrigo Antunes Cunha, Joaquim Alexandre Ribeiro · 2003 · Neuroscience Letters
  5. Deletion of presynaptic adenosine A1 receptors impairs the recovery of synaptic transmission after hypoxia
    Elda Arrigoni, Amanda J. Crocker, Clifford B. Saper, Robert W. Greene, Thomas E. Scammell · 2005 · Neuroscience
  6. Carbamazepine-Induced Upregulation of Adenosine A1-Receptors in Astrocyte Cultures Affects Coupling to the Phosphoinositol Signaling Pathway
    Knut P. H. Biber · 1999 · Neuropsychopharmacology
  7. 5′-Nucleotidase activity of mossy fibers in the dentate gyrus of normal and epileptic rats
    Siegfried W. Schoen, Ulrich Ebert, Wolfgang Löscher · 1999 · Neuroscience
  8. Stress and adenosine: II. Adenosine analogs mimic the effect of inescapable shock on shuttle-escape performance in rats.
    Thomas R. Minor, Jeffrey L. Winslow, Wei‐Chao Chang · 1994 · Behavioral Neuroscience
  9. Adenosine and Pituitary-Adrenocortical Axis Activity in the Rat
    Sergio Scaccianoce, Domitilla Navarra, Anna Di Sciullo, Luciano Angelucci, Elemér Endröczi · 2008 · Neuroendocrinology
  10. Somatic and Psychological Health Implications of Heavy Caffeine Use
    Jack E. James, John Crosbie · 1987 · British Journal of Addiction
  11. Suppression of hippocampal cell proliferation by short‐term stimulant drug administration in adult rats
    Linda J. Kochman, Casimir A. Fornal, Barry L. Jacobs · 2009 · European Journal of Neuroscience
  12. Alzheimer’s disease as a disorder of dynamic brain self-organization
    Thomas Arendt · 2004 · Progress in brain research
  13. Caffeine Dependence Syndrome
    Peter Bardsley · 1995 · JAMA
  14. Inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) mimics the effect of inescapable shock on escape learning in rats.
    James C. Woodson, Thomas R. Minor, R. F. Soames Job · 1998 · Behavioral Neuroscience
  15. Anticonvulsant effect and neurotransmitter modulation of focal and systemic 2-chloroadenosine against the development of pilocarpine-induced seizures
    Ghous M. Khan, Ilse Julia Smolders, Guy Ebinger, Yvette Madeleine Michotte · 2000 · Neuropharmacology
  16. Activation of adenosine A 1 receptors initiates short-term synaptic depression in rat striatum
    David M. Lovinger, Sukwoo Choi · 1995 · Neuroscience Letters
  17. The levels of adenosine and its metabolites in the guinea pig and rat brain during complete ischemia—in vivo study
    Tomoyuki Kobayashi, Takeshi Yamada, Yasuhiro Okada · 1998 · Brain Research
  18. Inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) mimics the effect of inescapable shock on escape learning in rats.
    James C. Woodson, Thomas R. Minor, R. F. Soames Job · 1998 · Behavioral Neuroscience
  19. The Adenosine Antagonist Theophylline Impairs P50 Auditory Sensory Gating in Normal Subjects
    Eduardo S. Ghisolfi · 2002 · Neuropsychopharmacology
  20. Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner
    Catarina A. Gomes, Sandra Henriques Vaz, Joaquim Alexandre Ribeiro, Ana Maria Sebastião · 2006 · Brain Research
  21. Changes in extracellular adenosine levels and population spike amplitude during graded hypoxia in the rat hippocampal slice
    John C. Fowler · 1993 · Naunyn-Schmiedeberg s Archives of Pharmacology
  22. The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine
    Kelly R. Powell, Paul Michael Iuvone, Stephen G. Holtzman · 2001 · Pharmacology Biochemistry and Behavior
  23. SCH 58261 (an adenosine A2A receptor antagonist) reduces, only at low doses, K+-evoked glutamate release in the striatum
    Annita Pintor, Davide Quarta, Antonella Pèzzola, Rosaria Reggio, Patrizia Popoli · 2001 · European Journal of Pharmacology
  24. Mechanism of adenosine accumulation in the hippocampal slice during energy deprivation
    David J. Doolette · 1997 · Neurochemistry International
  25. Effect of N-methyl-d-aspartate on motor activity and in vivo adenosine striatal outflow in the rat
    Alessia Melani, Claudia Corsi, Lydia Giménez‐Llort, Emili Martı́nez, Sven Ove Ögren, Felicita Pedata, Sergi Ferré · 1999 · European Journal of Pharmacology
  26. GDNF control of the glutamatergic cortico‐striatal pathway requires tonic activation of adenosine A2Areceptors
    Catarina A. Gomes, Patrícia F. Simões, Paula M. Canas, César Quiroz, Ana Maria Sebastião, Sergi Ferré, Rodrigo Antunes Cunha, Joaquim Alexandre Ribeiro · 2009 · Journal of Neurochemistry
  27. Therapeutic Opportunities for Caffeine in Alzheimer's Disease and Other Neurodegenerative Disorders
    Alexandre de Mendonça, Rodrigo Antunes Cunha · 2010 · Journal of Alzheimer s Disease
  28. Adenosine induces expression of glial cell line-derived neurotrophic factor (GDNF) in primary rat astrocytes
    Kazuo Yamagata, Kumiko Hakata, Aya Maeda, Chiemi Mochizuki, Hiroshi Matsufuji, Makoto Chino, Yukio Yamori · 2007 · Neuroscience Research
  29. Phenomenology and neurobiology of social phobia: comparison with panic disorder.
    Thomas W. Uhde, Manuel E. Tancer, B Black, T M Brown · 1991 · PubMed
  30. A1 adenosine receptors differentially regulate the N-methyl-d-aspartate and non-N-methyl-d-aspartate receptor-mediated components of hippocampal excitatory postsynaptic current in a Ca2+/Mg2+-dependent manner
    Andrei Klishin, Natasha A. Lozovaya, Oleg Krishtal · 1995 · Neuroscience
  31. Adenosine A1 and A2 receptor agonists significantly prevent the electroencephalographic effects induced by MK-801 in rats
    Patrizia Popoli, Rosaria Reggio, Antonella Pèzzola · 1997 · European Journal of Pharmacology
  32. Lower frequency of the low activity adenosine deaminase allelic variant (ADA1*2) in schizophrenic patients
    Gustavo Pimentel Dutra, Gustavo L. Ottoni, Diogo Rizzato Lara, Maurı́cio Reis Bogo · 2010 · Brazilian Journal of Psychiatry
  33. Cardiovascular effects of adenosine and its analogs in anaesthetized rats
    Luigi Stella, L. Berrino, Sabatino Maione, Vito de Novellis, Francesco Rossi · 1993 · Life Sciences
  34. Sympathetic activity relates to adenosine A2A receptor gene variation in blood-injury phobia
    Hohoff, C., Domschke, K., Schwarte, K., Spellmeyer, G., Vögele, C., Hetzel, G., Deckert, J., Gerlach, A. L. · 2009 · Journal of Neural Transmission
  35. Immunohistochemical analysis on the role of adenosine A1 receptors in epilepsy
    Tomoyo Ochiishi, Masatoshi Takita, Mitsushi J. Ikemoto, Hiroyasu Nakata, Shinya S. Suzuki · 1999 · Neuroreport
  36. The adenosine A1 receptor agonist N6-cyclopentyladenosine blocks the disruptive effect of phencyclidine on prepulse inhibition of the acoustic startle response in the rat
    Terrence L. Sills, Arezou Azampanah, Paul Fletcher · 1999 · European Journal of Pharmacology
  37. Brain‐Derived Neurotrophic Factor Protects Dopaminergic Cells from 6‐Hydroxydopamine Toxicity
    Mary Beth Spina, Carolyn Hyman, Stephen P. Squinto, Ronald M. Lindsay · 1992 · Annals of the New York Academy of Sciences
  38. Reduction of adenosine A1-receptors in the perforant pathway terminal zone in Alzheimer hippocampus
    Dick Jaarsma, Jantiena B. Sebens, Jakob Korf · 1991 · Neuroscience Letters
  39. Ornithine aminotransferase in Huntington's disease
    Peter T.‐H. Wong, Patrick L. McGeer, Martin N. Rossor, Edith G. McGeer · 1982 · Brain Research
  40. Anxiety and growth disturbance: is there a connection? A review of biological studies in social phobia.
    Thomas W. Uhde · 1994 · PubMed
  41. The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population
    Hideaki Kobayashi, Hiroshi Ujike, Nakao Iwata, Toshiya Inada, Mitsuhiko Yamada, Yoshimoto Sekine, Naohisa Uchimura, Masaomi Iyo, Norio Ozaki, Masanari Itokawa et al. · 2010 · Behavioral and Brain Functions
  42. Adenosine A1 receptors in the rat brain in the kindling model of epilepsy
    Michele Simonato, Katia Varani, Anna Muzzolini, Clementina Bianchi, Lorenzo Beani, Pier Andrea Borea · 1994 · European Journal of Pharmacology
  43. Helplessness and escape performance: glutamate-adenosine interactions in the frontal cortex.
    A. M. Hunter, B. Balleine, T. Minor · 2003 · Behavioral Neuroscience
  44. Ontogenetic profile of ectonucleotidase activities from brain synaptosomes of pilocarpine‐treated rats
    Giana de Paula Cognato, Alessandra Nejar Bruno, Fernanda Cenci Vuaden, João José Freitas Sarkis, Carla Denise Bonan · 2005 · International Journal of Developmental Neuroscience
  45. Quantitative electroencephalographic effects of caffeine in panic disorder
    Francis Newman, Murray B. Stein, Joan R. Trettau, Richard Coppola, Thomas W. Uhde · 1992 · Psychiatry Research Neuroimaging
  46. Alteration of adenosine A1 receptor binding in the post-ischaemic rat brain
    Haruo Nagasawa, Tsutomu Araki, Kyuya Kogure · 1994 · Neuroreport
  47. Remodeling of striatal NMDA receptors by chronic A2A receptor blockade in Huntington's disease mice
    Alberto Martire, Antonella Ferrante, Rosa Luisa Potenza, Monica Armida, Roberta Ferretti, Antonella Pèzzola, Maria Rosaria Domenici, Patrizia Popoli · 2009 · Neurobiology of Disease
  48. Reduced cortical ecto-ATPase activity in rat brains during prolonged status epilepticus induced by sequential administration of lithium and pilocarpine
    Agnes K. Nagy, Nancy Y. Walton, David M. Treiman · 1997 · Molecular and Chemical Neuropathology
  49. 5′-Nucleotidase Activity Indicates Sites of Synaptic Plasticity and Reactive Synaptogenesis in the Human Brain
    Ailing A. Lie, Ingmar Blümcke, Heinz Beck, Otmar Dieter Wiestler, Christian Erich Elger, Siegfried W. Schoen · 1999 · Journal of Neuropathology & Experimental Neurology
  50. The course of a seasonal bipolar disorder influenced by caffeine
    Leonardo Tondo, Nereide Rudas · 1991 · Journal of Affective Disorders
  51. Adenosine A2A Receptor Gene Disruption Provokes Marked Changes in Melanocortin Content and Pro‐Opiomelanocortin Gene Expression
    Sylvie Jégou, Malika El Yacoubi, Lourdes Mounien, Catherine A. Ledent, Marc Parmentier, Jean Costentin, Jean‐Marie Vaugeois, Hubert Vaudry · 2003 · Journal of Neuroendocrinology
  52. Association analysis of adenosine A1 receptor gene (ADORA1) polymorphisms with schizophrenia in a Japanese population
    Leo Gotoh, Hiroshi Mitsuyasu, Yuki Kobayashi, Naoya Oribe, Atsushi Takata, Hideaki Ninomiya, Vincent P. Stanton, Gregory M. Springett, Hiroaki Kawasaki, Shigenobu Kanba · 2009 · Psychiatric Genetics
  53. Adenosine modulation of d-[3H]aspartate release in cultured retina cells exposed to oxidative stress
    Paula M. Agostinho, Paula Caseiro, Ana Cristina Rego, Emı́lia P. Duarte, Rodrigo Antunes Cunha, Catarina Resende Oliveira · 2000 · Neurochemistry International
  54. Clinical Trials of Propentofylline in Vascular Dementia
    Barbara Kittner · 1999 · Alzheimer Disease & Associated Disorders
  55. Causality of stem cell based neurogenesis and depression – To be or not to be, is that the question?
    Robert E. Feldmann, Akira Sawa, Guenter H. Seidler · 2006 · Journal of Psychiatric Research
  56. Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group.
    B. Kittner · 2000 · PubMed
  57. Influence of CGS 21680, a selective adenosine A2A receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice
    Antonella Ferrante, Alberto Martire, Monica Armida, Valentina Chiodi, Antonella Pèzzola, Rosa Luisa Potenza, Maria Rosaria Domenici, Patrizia Popoli · 2010 · Brain Research
  58. 2-Chloro-N6-cyclopentyladenosine-elicited attenuation of evoked glutamate release is not sufficient to give complete protection against pilocarpine-induced seizures in rats
    Ghous M. Khan, Ilse Julia Smolders, Guy Ebinger, Yvette Madeleine Michotte · 2001 · Neuropharmacology
  59. In vivo effects of adenosine A2 receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo13C MR spectroscopy
    Janniche Hammer, Hong Qu, Asta Kristine Haberg, Ursula Sonnewald · 2001 · Journal of Neurochemistry
  60. In vitro Effect of Central Nervous System Active Drugs on the ATPase-ADPase Activity and Acetylcholinesterase Activity from Cerebral Cortex of Adult Rats
    Cláudia K. Barcellos, Maria Rosa Chitolina Schetinger, Renato Dutra Dias, J. J. F. Sarkis · 1998 · General Pharmacology The Vascular System
  61. Naloxone-sensitive, haloperidol-sensitive, [3H] (+) SKF-10047-binding protein partially purified from rat liver and rat brain membranes: An opioid/sigma receptor?
    Li-I Tsao, Tsung‐Ping Su · 1997 · Synapse
  62. Helplessness and escape performance: Glutamate-adenosine interactions in the frontal cortex.
    Aimee M. Hunter, Bernard Walter Balleine, Thomas R. Minor · 2003 · Behavioral Neuroscience
  63. N6-2-(4-Aminophenyl)ethyl-adenosine enhances the anticonvulsive activity of antiepileptic drugs
    Kinga K. Borowicz, Zdzislaw Kleinrok, Stanisław Jerzy Czuczwar · 1997 · European Journal of Pharmacology
  64. Serotonin, folic acid, and uric acid metabolism in the diagnosis of neuropsychiatric disorders.
    S.C. Brooks, J J Linn, N Disney · 1978 · PubMed
  65. Adenosine modulates corticotropin and cortisol release during hypoxia in fetal sheep
    Andrew Chau, James C. Rose, Brian J. Koos · 1999 · American Journal of Obstetrics and Gynecology
  66. Caffeinol at the Receptor Level
    Xiurong Zhao, Roger Strong, Paisith Piriyawat, Robert Palusiński, James C. Grotta, Jaroslaw A Aronowski · 2010 · Stroke
  67. Effect of adenosinergic modulation on the anticonvulsant effect of phenobartinone and carbamazepine
    J. Malhotra, Yogesh Kumar Gupta · 1999 · Methods and Findings in Experimental and Clinical Pharmacology
  68. The beginnings of hirudin
    Klaus Starke · 1989 · Trends in Pharmacological Sciences
  69. Adenosinergic psychopharmaceuticals?
    J. Deckkert, C. H. Gleiter · 1989 · Trends in Pharmacological Sciences
  70. Use of Lithium in the Medically Ill
    A. Amdisen, Jytte Hildebrandt · 2010 · Psychotherapy and Psychosomatics
  71. Role of The Purinergic Neuromodulation System in Epilepsy
    Ângelo R. Tomé, Henrique Bruno Lopes Silva, Rodrigo Antunes Cunha · 2010 · The Open Neuroscience Journal
  72. Chimaerins act downstream from neurotrophins in overcoming the inhibition of neurite outgrowth produced by myelin‐associated glycoprotein
    Tatsunori Mizuno, Toshihide Yamashita, Masaya Tohyama · 2004 · Journal of Neurochemistry
  73. Influence of adenosine, dipyridamole, adenosine antagonists and antiepileptic drugs on EEG after discharge following cortical stimulation.
    C Kulkarni, J David, T Joseph · 1997 · PubMed
  74. Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock
    Goncharuk · 2001 · Pure Amsterdam UMC
  75. Spatial and temporal expression of short, long/medium or both opsins in human fetal cones
    Xiao · 2000